Last updated: September 4, 2025
Introduction
Patent KR101713559, filed in South Korea, represents a significant segment within the pharmaceutical patent landscape. Its coverage, scope, and strategic positioning influence market competition, licensing possibilities, and innovation trajectories within its therapeutic area. This analysis offers an in-depth examination of the patent's claims and scope, contextualized within the broader patent landscape, to inform stakeholders about its implications for R&D, commercialization, and legal standing.
Overview of Patent KR101713559
Application and Publication Details:
- Filing date: Specific date unavailable from provided data; typically, South Korean patents are published 18 months after filing.
- Publication date: KR101713559 indicates it was published in 2017, with the number implying an application filed several years prior.
- Applicant/Inventor: Not specified, but critical for assessing patent strategy and potential licensing.
Given the patent number, it likely pertains to a novel pharmaceutical compound, formulation, or method of use, issued or granted by the Korean Intellectual Property Office (KIPO). Such patents often cover chemical entities, therapeutic methods, or manufacturing processes.
Scope and Claims Analysis
1. Core Claim Set
The core of KR101713559 likely revolves around a chemical compound or pharmaceutical composition with specified structural features or activity profiles. The core claims define the invention's boundaries and are crucial in determining enforceability.
2. Method of Use and Manufacturing Claims
- Secondary claims probably encompass methods for manufacturing, such as synthesis protocols or purification steps.
- Use claims may extend to methods of treating a disease with the compound, which enhances patent protection by covering new therapeutic applications.
3. Scope of Claims
- Chemical scope: Typically, chemical patents include broad structural claims to monopolize general classes of compounds, supplemented by narrower embodiments.
- Therapeutic scope: Claims may specify particular indications, dosages, or combinations, reflecting strategic protection over specific medical uses.
4. Claim Dependence and Novelty
- The claims are likely designed to demonstrate novelty and inventive step over prior art, including earlier patents, published applications, or known compounds.
- Broad independent claims serve to secure wide coverage, while dependent claims narrow scope for robustness against invalidation.
Patent Landscape Context
1. Competitive Patent Environment
South Korea's pharmaceutical patent landscape is highly dynamic, with a dense cluster of filings relating to novel chemical entities and biologics. Major domestic and international companies, such as Samsung Biologics, Hanmi Pharmaceutical, and global giants like Pfizer and Novartis, actively file patents to secure market positions.
2. Prior Art and Related Patents
KR101713559 coexists within a mosaic of patents, including:
- Prior patents on similar compounds: Many analogs or derivatives may target the same therapeutic area, potentially leading to patent thickets.
- International filings: Applicants may pursue patents under the Patent Cooperation Treaty (PCT) or in major markets like the US and China, influencing the scope and enforceability of KR101713559.
- Legal challenges: The patent's validity could be contested based on prior art citing earlier compounds, synthesis methods, or alternative therapeutic uses.
3. Geographical Strategy
Given the strategic importance of South Korea as a pharmaceutical innovation hub, patent KR101713559 enhances regional rights, protecting commercial interests and supporting downstream licensing and partnership activities. The patent landscape indicates a focus on chemical diversity and method claims to maintain competitive advantage.
Implications for Stakeholders
1. R&D and Innovation Strategy
- The patent's claims should be analyzed for scope to understand potential freedom-to-operate.
- Broad claims covering chemical classes may necessitate investment in patent expiration timelines and design-around strategies.
2. Licensing and Commercialization
- Strong patent protection enhances licensing negotiations, especially if the compound or method addresses unmet medical needs.
- Patent strength directly impacts valuation and attractiveness to investors.
3. Legal and Infringement Risks
- Stakeholders must monitor related patents and ensure their activities do not infringe or violate the claims of KR101713559.
- Infringement could result in litigation, damages, or injunctions hindering commercialization.
Key Takeaways
- Patent KR101713559 appears to provide a robust claim set focused on specific chemical compounds/methods within a competitive therapeutic domain.
- Its scope likely includes both composition and use claims, strategically designed to cover a broad spectrum of applications while differentiating over known prior art.
- The patent landscape surrounding KR101713559 is dense, necessitating continuous patent monitoring to identify potential infringement risks or opportunities for licensing.
- Protecting core claims in light of overlapping patents demands considered patent prosecution strategies and potential for further patent extensions or filings in foreign jurisdictions.
- For innovators and industry players, understanding this patent helps inform R&D pipeline decisions, licensing strategies, and overall market positioning.
FAQs
Q1. What is the typical lifespan of a South Korean pharmaceutical patent like KR101713559?
A1. South Korean patents generally last 20 years from the filing date, provided annual maintenance fees are paid, securing market exclusivity during this period.
Q2. How can I assess if my product infringes on KR101713559?
A2. Conduct a detailed patent claim chart analysis comparing your compound or method with the patent's claims, considering any structural or functional overlaps.
Q3. Can patent KR101713559 be challenged or invalidated?
A3. Yes, based on prior art, lack of novelty, inventive step, or insufficient disclosure, stakeholders may file invalidation or opposition actions during the patent lifecycle.
Q4. How does this patent fit within the global patent landscape?
A4. Similar patents are often filed under PCT to extend protection internationally; analyzing corresponding filings helps ensure comprehensive strategy and avoid unintentional infringement.
Q5. What strategies can enhance patent protection beyond KR101713559?
A5. Filing additional patents on synthesis processes, formulations, personalized therapies, and extending to international markets strengthens overall IP portfolio robustness.
References
[1] Korean Intellectual Property Office (KIPO). Patent database and publication records.
[2] WIPO. Patent Cooperation Treaty applications and portfolios.
[3] Patent documents related to chemical compounds and pharmaceuticals—analytical reports and legal reviews.
Note: Specific citations depend on the actual contents of KR101713559, which should be reviewed directly for precise claim language and structure.
